Cargando…
Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology
Scleroderma is an autoimmune disease that affects multiple systems. While pathophysiologic mechanisms governing the development of scleroderma are relatively poorly understood, advances in our understanding of the complement system are clarifying the role of complement pathways in the development of...
Autores principales: | Zuckerman, Roman, Asif, Arif, Costanzo, Eric J., Vachharajani, Tushar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Nefrologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533968/ https://www.ncbi.nlm.nih.gov/pubmed/29796581 http://dx.doi.org/10.1590/2175-8239-JBN-3807 |
Ejemplares similares
-
Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients
por: Raina, Rupesh, et al.
Publicado: (2018) -
Complement and the atypical hemolytic uremic syndrome in children
por: Loirat, Chantal, et al.
Publicado: (2008) -
Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab
por: Asif, Arif, et al.
Publicado: (2016) -
Complements Spurned: Our Experience with Atypical Hemolytic Uremic Syndrome
por: Nagar, Vidya S., et al.
Publicado: (2017) -
C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome: Two Important Manifestations of Complement System Dysfunction
por: Bajwa, Ravneet, et al.
Publicado: (2018)